President Donald Trump’s freeze on U.S. foreign aid has temporarily suspended key anti-narcotics programs in Mexico, impacting efforts to curb the flow of fentanyl into the U.S. The freeze affects all programs under the State Department’s Bureau of International Narcotics and Law Enforcement (INL), which trains Mexican authorities to dismantle clandestine fentanyl labs and intercept precursor chemicals.
INL initiatives, including drug-detecting canines that helped seize millions of fentanyl pills in 2023, have been put on hold. Former State Department official Dafna H. Rand criticized the freeze, stating it weakens the U.S.'s ability to combat the fentanyl crisis, which has claimed over 450,000 American lives in the past decade.
The freeze follows Trump’s "America First" policy, halting billions in foreign assistance worldwide. Despite Secretary of State Marco Rubio issuing waivers for humanitarian aid, most programs remain in limbo. Some officials suggest exemptions for foreign anti-narcotics programs are being considered, though no decision has been made on INL’s Mexico projects.
Trump has pledged to destroy Mexican cartels and threatened 25% tariffs on Mexico if it fails to curb fentanyl trafficking and illegal immigration. He has also pushed for designating cartels as terrorist organizations, expanding U.S. authority to target them. U.S. military surveillance of Mexican cartels has increased, raising concerns that Trump’s approach is shifting from cooperation with Mexico to unilateral action.
During his campaign, Trump called for military operations against cartels, signaling a tougher stance. While the administration’s next steps remain uncertain, the suspension of INL programs has stalled critical efforts to combat fentanyl at its source, complicating U.S.-Mexico cooperation on drug enforcement.


China Warns US Arms Sales to Taiwan Could Disrupt Trump’s Planned Visit
U.S. Condemns South Africa’s Expulsion of Israeli Diplomat Amid Rising Diplomatic Tensions
NATO to Discuss Strengthening Greenland Security Amid Arctic Tensions
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Supreme Court Signals Skepticism Toward Hawaii Handgun Carry Law
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Supreme Court Signals Doubts Over Trump’s Bid to Fire Fed Governor Lisa Cook
U.S. Lawmakers to Review Unredacted Jeffrey Epstein DOJ Files Starting Monday
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Federal Judge Rules Trump Administration Unlawfully Halted EV Charger Funding
Federal Judge Blocks Trump Administration Move to End TPS for Haitian Immigrants
Citigroup Faces Lawsuit Over Alleged Sexual Harassment by Top Wealth Executive
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Federal Judge Restores Funding for Gateway Rail Tunnel Project
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 



